Clinical Trials · NCT06954090
Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study
- Phase
- Phase 4
- Recruitment status
- Enrolling By Invitation
- Sponsor
- Steno Diabetes Center Copenhagen
- Enrollment
- 50
- Start date
- Nov 2025
- Locations
- 1 site, Denmark
- Primary endpoint
- Proteomic feasibility